However, we could rule out both pathways as drivers of constitutive IκBζ expression in melanoma, as neither the presence of activating BRAF or NRAS mutations nor increased NF-κB activity correlated with constitutive IκBζ protein expression. This evidence concerns the gene NFKB1 and melanoma.